<DOC>
	<DOCNO>NCT00383227</DOCNO>
	<brief_summary>Comparison adjuvanted hepatitis B vaccine double dose Engerix™-B pre- /haemodialysis patient age ≥15 year</brief_summary>
	<brief_title>Comparison Adjuvanted Hepatitis B Vaccine Double Dose Engerix™-B Pre- /Haemodialysis Patients Aged ≥15 Years</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female &gt; = 15 year age time first vaccination . Written inform consent obtain subject/ parent guardian subject . Seronegative antiHBs antibody , antiHBc antibody &amp; Hepatitis B Surface antigen ( HBsAg ) . If subject female , nonchildbearing potential , childbearing potential , abstinent use adequate contraceptive precaution one month prior enrollment two month last vaccination . Prehaemodialysis patient* patient haemodialysis . Use investigational nonregistered drug vaccine study vaccine study period within 30 day precede first dose study vaccine . Previous vaccination hepatitis B . History hepatitis B infection . Known exposure hepatitis B virus within 6 week . Pregnant lactate female Clinically abnormal ALT/AST value ( &gt; 3 time normal value )</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>